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The physiological wound healing process involves a cascade of events which could
be affected by several factors resulting in chronic, non-healing wounds. The latter
represent a great burden especially when bacterial biofilms are formed. The rise
in antibiotic resistance amongst infectious microorganisms leads to the need of
novel approaches to treat this clinical issue. In this context, the use of advanced
biomaterials, which can enhance the physiological expression and secretion of the
growth factors involved in the wound healing process, is gaining increasing attention
as a robust and appealing alternative approach. Among them, mesoporous glasses
are of particular interest due to their excellent textural properties and to the possibility
of incorporating and releasing specific therapeutic species, such as metallic ions.
One of the most attractive therapeutic ions is copper thanks to its proangiogenic
and antibacterial effects. In this contribution, copper containing mesoporous glass
nanoparticles were proposed as a multifunctional device to treat chronic wounds.
The developed nanoparticles evidenced a very high specific surface area (740 m2/g),
uniform pores of 4 nm and an almost total release of the therapeutic ion within 72 h
of soaking. The produced nanoparticles were biocompatible and, when tested against
Gram positive and Gram negative bacterial species, demonstrated antibacterial activity
against both planktonic and biofilm bacteria in 2D cell monolayers, and in a 3D human
model of infected skin. Their proangiogenic effect was tested with both the aortic
ring and the chick chorioallantoic membrane assays and an increase in endothelial
cell outgrowth at a concentration range between 30 and 300 ng/mL was shown.
Overall, in this study biocompatible, multifunctional Cu-containing mesoporous glass
nanoparticles were successfully produced and demonstrated to exert both antibacterial
and proangiogenic effects.
Keywords: biomaterials, antibacterial, proangiogenic, multifunctionality, glass nanoparticles, mesoporous,
chronic wound and burn healing
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INTRODUCTION
The rise in antibiotic resistance (AMR) amongst infectious
microorganisms is a current and increasing global threat
(Shallcross et al., 2015; O’Neill, 2016). There is a dire need for
novel or repurposed antimicrobials that do not rely on traditional
antibiotics and that will not contribute to AMR.
Metal ions, such as silver and copper, are one such set of
antimicrobials that are currently of interest as they can be
combined with functional materials for designing healthcare
devices (Gorzelanny et al., 2016; Liu et al., 2016; Ramasamy
and Lee, 2016; Sun et al., 2016; Bayramov and Neff, 2017).
Whilst there is some evidence that bacteria can develop resistance
mechanisms to certain forms of copper and silver (Percival
et al., 2005; Santo et al., 2011; Finley et al., 2015; Hobman and
Crossman, 2015; Williams et al., 2016), they are still promising
as antimicrobials due to their broad ranges of biocidal activity
against multiple microorganisms, including both Gram positive
and Gram negative bacteria. Evidence also exists that metal ions
such as silver and copper are either directly antifungal or enhance
the actions of antifungal agents (Gomes da Silva Dantas et al.,
2018; Radhakrishnan et al., 2018).
One of the main problems with chronic infections is
the formation of bacterial biofilms. These are complex,
heterogeneous 3D multilayered communities of bacteria encased
within a polysaccharide matrix. Traditional antimicrobials can
be orders of magnitude less effective against biofilm bacteria
than against their “free floating” planktonic counterparts (Koo
et al., 2017) for several reasons. The polysaccharide matrix forms
a protective barrier which some antibiotics cannot penetrate
(Limoli et al., 2015; Flemming et al., 2016), and the biofilm
community contains dormant “persister” cells that are not
actively dividing and therefore several antibiotic targets, such as
cell wall synthesis, are not available (Amato et al., 2014; Brauner
et al., 2016). Biofilms can form on almost any surface, organic or
inorganic, and biofilms that formwithin wounds, such as diabetic
foot ulcers and burn wounds generate a huge socioeconomic
burden (Sen et al., 2009). Therefore, advances in prevention and
novel effective approaches for the treatment of such biofilms
are important. Toward the development of novel antimicrobial
approaches the authors previously established a 3D tissue
engineered model of bacterial infected human skin, constructed
from a scaffold of decellularised human dermis seeded with
human keratinocytes and dermal fibroblasts (MacNeil et al.,
2011) which is then thermally injured and infected with bacteria
(Shepherd et al., 2009). This model has proven useful in the
testing of several novel antimicrobials (Bertal et al., 2009;
Shepherd et al., 2011; Zheng et al., 2019) and in performing basic
infection studies (Bullock et al., 2019).
Among the wide class of advanced biomaterials, mesoporous
bioactive glasses (MBGs) have attracted increasing attention
to develop alternative and promising antibacterial strategies,
primarily because of their capability to release therapeutic
dosages of antimicrobial agents (Kargozar et al., 2018), thanks
to the excellent exposed surface area and accessible uniform
nanochannels (Vallet-Regí, 2010). More recently, several studies
proved that the incorporation of selected therapeutic ions into
the MBG framework imparts specific biological functions, such
as antibacterial, proosteogenic and proangiogenic effects (Hoppe
et al., 2011; Wu and Chang, 2014).
Among the therapeutic ions which can exert multifunctional
actions, copper has been extensively investigated with the
aim of improving the biological effect of MBGs, due to
the recognized proangiogenic effect of copper alongside its
antibacterial potential (Wu et al., 2013; Wang et al., 2016).
Several studies have proven the antibacterial potential of Cu-
substituted MBGs against both planktonic bacteria and biofilms.
Wu et al. (2013) tested the antibacterial potential of Cu-
containing MBG scaffolds and showed that the number of viable
Escherichia coli bacteria were significantly reduced after 7 days
of incubation, ascribing this effect to the redox potential of
copper and the concomitant production of hydroxyl radicals
which are detrimental to the bacteria. Consistent with this,
the authors recently reported (Bari et al., 2017) that Cu-
containing MBG nanoparticles and their ionic extracts exerted
promising antibacterial activity against both Gram positive and
Gram negative bacteria (Staphylococcus aureus, Staphylococcus
epidermidis and E. coli) and were effective in inhibiting and
preventing biofilm produced by S. epidermidis.
Since the process of wound healing in soft tissue requires
revascularization of the affected area, the stimulation of
angiogenesis would be an advantage in a therapeutic setting.
Can such ion-substituted MBGs be really multifunctional
and simultaneously act as proangiogenic and antimicrobial
agents, thus providing novel, effective alternatives to traditional
therapeutic approaches?
There are various approaches to study proangiogenic
properties of bioactive substances, both ex- and in vivo. Ex-
vivo, an aortic ring assay can be used in which aortas
(embryonic chicken, mouse, or rat) are excised, cut into rings,
embedded into an extracellular matrix gel and treated. The
numbers of neo-vessels sprouting from the aortic ring can
be quantified (Nicosia and Ottinetti, 1990). Concerning the
in vivo approaches, there are several other methods available
including the extensively used chick chorioallantoic membrane
(CAM) assay, widely used since its first development due
to the visibility and accessibility of the highly vascularised
membrane in fertilized chicken eggs (Nowak-Sliwinska et al.,
2014). Using other methods, Lin and co-workers (Lin et al.,
2016) demonstrated that the growth of new vessels in the
fibrous tissue of rat calvaria defects was promoted by copper
ions released from a copper-containing bioactive glass scaffold.
Romero-Sánchez et al. (2018) explored the angiogenic effect
exerted by the ionic products of both MBG and Cu-containing
MBG. The proangiogenic effect of Cu-containing MBGs was
confirmed by the increase in vessel number and thickness of
the sub intestinal venous plexus (SIVP) in the in vivo zebrafish
embryo assay.
Moreover, the close connection between osteogenesis
and angiogenesis was confirmed by Li and co-workers (Li
et al., 2017) through in vivo experiments in a goat model
after anterior cruciate ligament (ACL) reconstruction which
demonstrated that the Cu-substituted bioactive glass could
promote bone regeneration.
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Following on from this, in this contribution copper-
containing MBG nanoparticles are proposed as a multifunctional
agent to treat chronic wounds, able to target both antibacterial
infections and to promote neovascularisation. To this aim, the
authors assessed the antibacterial potential, both in biofilm
models and in the infected tissue engineered skin model, and
investigated the proangiogenic activity using aortic rings and in
vivo CAM assays.
MATERIALS AND METHODS
MBG and Cu-Substituted MBG
Nanoparticles
Cu-substituted MBGs with the following nominal molar
composition 85SiO2/13CaO/2CuO %mol were produced by
following a synthesis procedure optimized by the authors
(Bari et al., 2017). Briefly, 6.6 g of cetyltrimethylammonium
bromide (CTAB, ≥ 98%, Sigma Aldrich) and 12mL of
ammonium hydroxide solution (NH4OH, Sigma Aldrich) were
dissolved by stirring for 30min in 600mL of double distilled
water. Into this solution, 30mL of tetraethyl orthosilicate
(TEOS, 99%, Sigma Aldrich), 4.888 g of calcium nitrate
tetrahydrate (Ca(NO3)2·4H2O, 99%, Sigma Aldrich) and 0.428
of copper chloride (CuCl2, 99%, Sigma Aldrich) were dissolved,
under stirring for 3 h. Then, the powders were separated by
centrifugation at 10,000 rpm for 5min (Hermle Labortechnik
Z326), washed one time with distilled water and two times with
ethanol. The final precipitate was dried at 70◦C for 12 h. Finally,
the powders were calcined at 600◦C in air for five at a heating
rate of 1◦C/min using a Carbolite 1300 CWF 15/5. The obtained
calcined powders will be referred hereafter as Cu-MBG.
The same route was followed in order to produce a
reference sample without copper with the following nominal
molar composition 85SiO2/15CaO (%mol) and named hereafter
as MBG.
Physico-Chemical Characterization of
MBG and Cu-MBG
The morphology of produced nanoparticles was investigated by
Field Emission Scanning Electron Microscopy (FE-SEM) using
a ZEISS MERLIN instrument. In order to perform the FE-
SEM analysis, 10mg of powders were dispersed in 10mL of
isopropanol using the Digitec DT 103H (Bandelin) ultrasonic
bath for 5min. Then, 5 µL of the resulting stable suspension
were dropped on a carbon coated copper grid and coated with
5 nm of Cr layer. Compositional characterization of the sample
was carried out by Energy Dispersive Spectroscopy (EDS; Aztec
EDS, Oxford instruments). Wide-angle X-ray diffraction (WA-
XRD) investigation of the samples was performed by using the
XRD, X’Pert PRO (PANanalytical).
The nitrogen adsorption-desorption measurements at
−196◦C were performed using an ASAP2020, Micromeritics.
Samples were outgassed at 150◦C for 5 h before analysis.
The Brunauer-Emmett-Teller (BET) equation was adopted to
calculate the specific surface area (SSA) from the adsorption
data, in the range of 0.04–0.2 p/p0. The pore size distribution
was calculated by the DFT method (Density Functional
Theory) using the NLDFT kernel of equilibrium isotherms
(desorption branch).
Copper Ion Release Test From Cu-MBG
To evaluate the Cu ion release, 5mg of Cu-MBG were suspended
in 20mL of Tris HCl buffer (Tris(hydroxymethyl) aminomethane
(Trizma) (Sigma Aldrich) 0.1M, pH 7.4) at a final concentration
of 250µg/mL, according to the protocol reported by Shi et al.
(2016). The samples were kept immersed for different time points
up to 14 days at 37◦C in an orbital shaker Excella E24 with an
agitation rate of 150 rpm. At each predefined time point (3 h, 24 h,
3 d, 7 d, and 14 d) the suspensions were centrifuged for 5min at
10,000 rpm (Hermle Labortechnik Z326), half of the supernatant
was collected and replaced by the same amount of fresh buffer.
The ion concentration in the supernatant solution was
obtained by ICP (ICP-MS, Thermoscientific, ICAPQ), after
appropriate dilutions. Each experiment was carried out
in triplicate.
Evaluation of Cytotoxicity and
Anti-bacterial Properties
Construction of 3D Tissue Engineered Skin
3D tissue engineered skin constructs were prepared as described
previously (MacNeil et al., 2011). Briefly, human dermal
fibroblasts were isolated from split-thickness skin biopsies
received from abdominoplasties and breast reductions performed
at the Northern General Hospital, Sheffield in accordance with
NHS Research ethics approvals (Ref: 15/YH/0177). Research
Ethics approval was obtained from the Sheffield Research
Ethics Committee. Donors gave informed and written consent.
Cells were maintained in DMEM high glucose (4,500 mg/L
glucose), 10% v/v fetal calf serum (FCS), 2mM l-glutamine,
0.625 mg/mL amphotericin B, 100 IU/ mL penicillin, and 100
mg/mL streptomycin (all Sigma Aldrich, UK). Keratinocytes
(HaCaT) cells were purchased from Promega and maintained
in Greens media (DMEM high glucose (4,500 mg/L glucose)
and Ham’s F12 medium in a 3:1 ratio, 10% v/v FCS,
10 ng/mL human recombinant epidermal growth factor, 0.4
mg/mL hydrocortisone, 10–10M cholera toxin, 18mM adenine,
5 mg/mL insulin, 5 mg/mL apo-transferrin, 20mM 3,3,5-tri-
idothyronine, 2mM glutamine, 0.625 mg/mL amphotericin
B, 100 IU/mL penicillin, and 1,000 mg/mL streptomycin).
Decellularised dermis (DED), produced by removing cells using
1M NaCl as detailed in MacNeil et al. (2011) from human
cadaver skin (Euro Skin, ethical approval for research not
required by user), was used as a base scaffold. Rings of DED
(15mm in diameter) were cut and placed within 12mm tissue
culture inserts with 4mm pores in the base (Greiner). Inserts
were suspended from the edges of 12 well plates into the wells.
Greens medium containing 10% fetal calf serum was added to
the bottom of the wells so that it lapped the under surface of the
DED. The DED was then seeded with 1× 105 fibroblasts and 5×
105 keratinocytes, each in 250mL of 10%Greens medium. Again,
after 24 h incubation at 37◦C, seeding medium was removed and
replaced with fresh Greens. After a further 24 h, medium was
removed from inside the inserts in order to leave the constructs
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at an air/liquid interface. Greens medium in the tissue culture
wells was replaced every 24 h and constructs were used for
experimentation after 14 days at air/liquid interface.
Cytotoxicity Testing
The toxicity of two concentrations of MBG and Cu-MBG was
tested using monolayers of human primary fibroblasts isolated
from excess skin from abdominoplasties as described previously
(MacNeil et al., 2011). Human primary fibroblasts were seeded
at a density of 100,000 cells per well in a 24 well sterile tissue
culture plate in 1mL of Dulbecco’s minimal essential medium
(DMEM) (Sigma Aldrich) and incubated overnight at 37◦C/5%
CO2 to form a monolayer. MBG and Cu-MBG were added to
the wells with fresh media to a final concentration of either 0.1
or 1 mg/mL in 1mL of total suspension. Dimethyl sulphoxide
(DMSO, Sigma Aldrich) was used as a positive toxicity control
with 0.5mL added into the well. Cells without any treatment were
used as negative toxicity controls. Plates were then incubated for
48 h at 37◦C/5%CO2 and then analyzed using themetabolic assay
PrestoBlueTM. For the assay, all medium was removed and 700
µL of a 1:10 dilution of PrestoBlue:DMEM were added for 1 h.
300 µL in duplicate were removed from the 24 well plate and
added to a 96 well plate for reading. Fluorescence was then read
with excitation/emission wavelengths of 560 nm/590 nm using a
Tecan spectrophotometer.
3D skin samples were incubated in 1mL of Greens media with
0.1 mg/mL Cu-MBG suspensions. As reference material, Acticoat
Flex 3 (Smith & Nephew), a commercial coating for infected
wounds, was cut in 5× 5mm sections and incubated in the same
conditions. Samples were incubated for 24 h at 37◦C/5% CO2.
After the removal of the incubation medium and of Acticoat Flex
3 sections, 3D skin samples were washed with phosphate buffered
saline (PBS) and tested for cell metabolism using the PrestoBlue
assay, as above.
Bacteria
Antibacterial properties of nanoparticles were tested against
clinical isolates of S. aureus (S235) and Pseudomonas aeruginosa
(SOM-1), representative of Gram positive and Gram negative
bacteria respectively that commonly infect chronic skin wounds.
Both species were cultured in brain heart infusion (BHI) broth
(Oxoid, UK) at 37◦C overnight and stored at 4◦C on BHI agar
(Sigma Aldrich, UK).
Infection of Skin Constructs
Constructs were washed in antibiotic-free Greens medium for
72 h prior to infection. They were then burnt using application
of a surgical cauterizer for 8 s immediately prior to infection in
order to provide the bacteria with amode of entry into the dermal
tissue. 1 × 106 P. aeruginosa or S. aureus cells in 20 µL BHI
broth per construct were pipetted into the inserts covering the
epidermal surface. Infected constructs and non-infected controls
were incubated at 37◦C/ 5% CO2.
Measurement of Antibacterial Activity Against
Planktonic Bacteria
The antibacterial activity of both Cu-MBG and MBG
nanoparticles against planktonic S. aureus S235 and P.
aeruginosa SOM-1 was determined by suspending the particles
at a concentration of 100µg/mL in sterile phosphate buffered
saline (PBS) and incubating the resulting suspension with
bacterial broth cultures. 100 µL of nanoparticle suspension at
100µg/mL concentration were incubated at 37◦C with 100 µL of
a suspension of bacteria at a concentration of ∼1 × 1010 colony
forming units per mL (cfu/mL). Following incubation for 24 h,
serial dilutions of each sample were performed, and viable counts
carried out according to the standard Miles & Misra technique
by spotting out dilutions onto BHI agar plates and counting the
numbers of cfu/mL after incubating plates for 24 h at 37◦C.
Measurement of Antibacterial Activity Against
Bacterial Biofilms
To test antibacterial activity against bacterial biofilms, two
techniques were used to measure both prevention of biofilm
formation and biofilm disruption. Clinical isolates of P.
aeruginosa and S. aureus, as detailed above, were used to form
48 h biofilms in BHI broth on tissue culture plastic. Overnight
cultures of bacteria were diluted 1:100 in BHI broth and
incubated at 37◦C for 48 h, either with addition of 0.1 mg/mL
Cu-MBG at the time of inoculation (to test prevention of biofilm
formation) or after 48 h when the biofilms had formed (to
test biofilm disruption). In the case of biofilm disruption, 48 h
biofilms were incubated with 0.1 mg/mL Cu-MBG suspensions
for 24 h before performing assays as follows:
i) Absorbance of the whole sample (planktonic and biofilm
bacteria) was read at 600 nm to measure the entire biomass
using a Tecan spectrophotometer with Magellan software.
Following this, planktonic bacteria were removed and the
absorbance at 600 nm ensured the measure of the biofilm
mass alone;
ii) To measure metabolic activity, PrestoBlue assays were run
on the biofilm according to manufacturer’s instructions.
Briefly, biofilms cultured in 12 well plates were incubated
with 1mL 1xPrestoBlue reagent (ThermoFisher) at
37◦C for 1 h. Fluorescence was then measured with
excitation/emission wavelengths of 560 nm/590 nm using a
Tecan spectrophotometer as above.
Antibacterial Activity in Infected 3D Skin Models
The disruption of biofilm forming ability was tested by adding
0.1 mg/mL of Cu-MBG suspension to the skin simultaneously
to the bacteria and incubated for 24 h before measuring bacterial
viability. To investigate if the samples could disrupt a pre-existing
biofilm the samples were added to the skin 24 h after infection
with bacteria. The skin was then left incubating at 37◦C/5%CO2
for a further 24 h before surviving bacterial numbers were
counted. At the testing point the tissue was weighed, then
homogenized in 1mL BHI broth. The resulting homogenates
were diluted serially and used to perform viable counts of bacteria
in the samples using standard Miles & Misra methods as above.
Proangiogenesis Effect
Aortic Ring Assay
Aortas from 12-days old chicken embryos were harvested under
sterile conditions and cut into 4–5 rings of <1mm length after
removing fat and membranous tissue from around the vessel
(∼4–5mm long). Rings were embedded in 80 µL of extracellular
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matrix gel (ECM gel, Sigma Aldrich) in wells of 48 well plates.
After allowing the ECM gel to gel at 37◦C for 20min, alpha
MEMmedia (Sigma Aldrich) supplemented with 2% FCS (Sigma
Aldrich) was gently added to the well.
The dissolution extracts of MBG and Cu-MBG were prepared
by suspending the powder at different concentrations (1 mg/mL,
300µg/mL, 100µg/mL, and 30µg/mL) in alpha MEM growth
media at 4◦C for 72 h. After the incubation the powders were
removed from the suspension by filtration, and the resulting
solution extracts were used for the aortic ring experiments. VEGF
was used as a positive control to treat aortic rings at 3, 10, and 30
ng/mL dosage.
Outgrowth from rings was captured by photography (40x
magnification) every 24 h for 5 days and 48 h was chosen as a time
point to compare outgrowth between the tested particle extracts
and controls. Outgrowth was measured by tracing the outline of
the area covered by the outgrowth of endothelial sprouts/network
then subtracting the area covered by the original aortic ring using
ImageJ software.
CAM Assay
Chicken eggs obtained within 24 h of laying were incubated
for 72 h at 37◦C, then removed from their shells into sterile
containers placed inside Petri dishes. After verifying the presence
of a living embryo, the ex ovo eggs/embryo were incubated
for a further 4 days at 37◦C. Both MBG and Cu-MBG were
applied to the CAM membrane. 100 µL of particle suspension
bearing 1mg of nanomatrix powder in PBS were placed within
a 0.7mm diameter polypropylene ring on the CAM membrane,
and the egg incubated for a further 3 days. The CAM membrane
around the ring bearing the nanoparticle treatment was then
photographed. To quantify the change in vasculature, green
channel images of the CAM were created from the original
RGB (red, green, blue) images. These were then analyzed using
Angiotool (National Cancer Institute, Washington USA). Data
is presented as an average of three experiments, each using six
eggs per treatment group, ± Standard Error of the Mean (SEM).
Statistical significance was determined by T-test, and p < 0.05
deemed to be significant.
RESULTS
Nanoparticle Characterization
MBG and Cu-MBGmorphology was explored by FE-SEM which
revealed uniform spherical particles, with sizes ranging between
100 and 150 nm, as shown in Figures 1A,C. The EDS spectra of
the powder dispersed on carbon tape (Figures 1B,D) confirmed
the theoretical composition of the samples. In particular, the
EDS investigation of Cu-MBG (Figure 1D) suggested that the
incorporation of copper inside the framework successfully
occurred with a Cu/Si molar ratio (as an average of three
measurements) very close to the nominal ratio.
The amorphous state of both MBG and Cu-substituted MBG
was confirmed by WA-XRD analysis (data not shown) which
evidenced only the broad peak at around 20◦ 2θ, typical of
amorphous silica-based systems.
The N2 adsorption-desorption measurements confirmed the
mesoporous structure of both MBG (Figure 2A) and Cu-MBG
(Figure 2B) which show a IV type isotherm. Cu-MBG (inset in
Figure 2B) displays a single-mode pore size distribution centered
FIGURE 1 | (A) FE-SEM image of MBG, (B) EDS spectrum of MBG; (C) FE-SEM image of Cu-MBG, (D) EDS spectrum of Cu-MBG.
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FIGURE 2 | (A) N2 adsorption-desorption isotherm of MBG and related DFT pore size distribution (inset); (B) N2 adsorption-desorption isotherm of Cu-MBG and
related DFT pore size distribution (inset).
at 4 nm, whereas the hysteresis loop in Figure 2A indicated a
broad pore size distribution for MBG, confirmed also by the inset
in Figure 2A.
The SSA and pore volume of the obtained systems are
listed in Table 1. The very high values, especially for Cu-MBG,
demonstrated that the incorporation of a metal ion did not
negatively affect the formation of the mesoporous structure, as
with data reported for similar systems (Bari et al., 2017; Fiorilli
et al., 2018). This is in good accordance with data reported by
Wang et al. (2016) who demonstrated that the incorporation
of copper up to 2% mol concentration improved the structural
features of MBGs by inducing an increase of the specific surface
area and pore volume.
The capability of Cu-MBG to release the therapeutic ions was
confirmed by soaking the powder in Tris HCl. In agreement to
that reported by one of the authors group (Pontremoli et al.,
2018), a burst release was encountered within the first 3 h of
incubation and almost the total amount of incorporated copper
TABLE 1 | Structural features of Cu-MBG.
Name Specific surface area
(m2/g)
Pore size
(nm)
Volume
(cm3/g)
MBG 476 4.5–5.5 0.57
Cu-MBG 740 4 0.65
was released after 3 days of soaking, reaching a concentration of
4.5 ppm.
Cytotoxicity
At 1 mg/mL, MBG nanoparticles were not toxic to human
cells tested, but Cu-MBG nanoparticles at 1 mg/mL reduced
cellular metabolic activity by ∼20% (Figure 3A). No significant
difference in metabolism to MBG treated cells was found for
Cu-MBG at a concentration of 0.1 mg/mL. This defined the
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FIGURE 3 | Toxicity of Cu-MBG tested against mammalian cells. (A) Toxicity of two different concentrations of MBG and Cu-MBG against a monolayer of human
primary fibroblasts over 48 h exposure assessed by metabolic activity measured using a PrestoBlue assay. (B) Toxicity of Cu-MBG and of industrial standard silver
dressing Acticoat Flex 3 on tissue engineered skin models after 24 h of exposure in model assessed by metabolic activity measured using a PrestoBlue assay. Mean ±
standard deviation, ANOVA test used with *p < 0.05.
concentration used for the remainder of the study and thus a
0.1 mg/mL concentration was then tested on a more complex
model, the tissue engineered skin. The toxicity of Cu-MBG at 0.1
mg/ml concentration was well-tolerated, whereas in comparison
a commercially available silver-containing dressing (Acticoat Flex
3) markedly inhibited cell viability in the 3D tissue engineered
skin model (Figure 3B).
Antibacterial Effects Against Planktonic
Bacteria
Cu-MBG at 100µg/mL had significant antibacterial effects
against clinical isolates of both P. aeruginosa and S. aureus when
in planktonic form, with 1.2–3.5 log reductions in viable numbers
of bacteria from control (PBS treated) samples (Figure 4). No
antibacterial effect was seen with unloaded MBG nanoparticles,
so these were not tested in further antibacterial assays.
Antibacterial Effects Against Biofilms
For both species of bacteria tested, exposure to Cu-MBG
reduced the existing biofilm (Figures 5A,C) or helped prevent
its formation (Figures 5B,D) when considering both biofilm
biomass and biofilm metabolic activity. Metabolic activity was
greatly reduced for P. aeruginosa and to a lesser, but still
significant extent, for S. aureus after treatment with Cu-MBG.
Optical density measurements (Figures 5C,D) revealed that the
mass of biofilm present after treatment is reduced for both
species. The remaining P. aeruginosa biofilms after treatment
appear to contain no metabolically active cells after treatment.
Antibacterial Action of Cu-MBG in a Model
of Infected Skin
In contrast to the microbiology results on biofilm reported
above, the impact of Cu-MBG against P. aeruginosa was far
less pronounced than its action against S. aureus in the infected
skin model. No statistical significance was found between P.
FIGURE 4 | Antibacterial effects of Cu-MBG against planktonic bacteria.
Colony forming units per mL of broth were measured following 24 h incubation
of bacteria in suspension +/– 100µg/mL Cu-MBG or MBG. There was a
decrease in viable numbers of both species with Cu-MBG—a 3.5-log
reduction in viable P. aeruginosa and 1.2-log reduction in S. aureus. No
reduction in bacterial numbers was measured after incubation with unloaded
MBG particles. n = 3, error bars = SEM, t-test performed. *p< 0.05.
aeruginosa controls and the treated samples (Figure 6).While the
industrial standard Acticoat Flex 3 was more effective than Cu-
MBG against P. aeruginosa infection in a 3D skin model, it was
of similar effectiveness against S. aureus for both prevention and
disruption of biofilms in the infected skin model.
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FIGURE 5 | Antibiofilm testing using Cu-MBG samples, measured using biofilm bacteria viability (metabolic assay) (A,B) and biofilm biomass (optical density) (C,D).
(A) Cu-MBG preventative action on the formation of biofilms using the measure of bacterial metabolic activity. (B) Cu-MBG ability to disrupt pre-formed biofilms using
the measure of bacterial metabolic activity. (C) Cu-MBG preventative action on the formation biofilms using the measure of optical density of the biofilm with higher
values indicating greater biofilm formation. (D) Cu-MBG ability to disrupt a pre-formed biofilm using the measure of optical density of the biofilm with higher values
indicating greater biofilm formation. n = 3, means ± standard deviation, ANOVA statistics used with *p < 0.05.
Assessment of Proangiogenic Activity of
Cu-MBG
Aortic Ring Assay
Endothelial cell outgrowth began by 24 h for the majority of
aortic rings but was prominent enough to be measured by 48 h.
Cell outgrowth from the aortic rings formed branching networks
(Figure 7). By 72 h, many wells had outgrowths which extended
beyond the field of view, making accurate measurement difficult.
For this reason, we chose a set time point of 48 h for initial
calculations. The data is presented as the area of endothelial
outgrowth in mm2.
VEGF was used as a positive control in the aortic ring assay.
Treatment promoted an increase in the rate of cell outgrowth,
which appeared to be maximal by 10 ng/mL VEGF (Figure 8).
The area of outgrowth increased from 0.3 to 1.5 mm2 with the
addition of VEGF representing an∼5-fold increase in the area of
outgrowth. With both MBG and Cu-MBG there was an increase
in outgrowth with doses of 30 to 300µg/mL, compared to control
media. A decrease in outgrowth was observed at 1 mg/mL for
both MBG and Cu-MBG (Figure 8).
Assessment Using the CAM Assay
Image analysis of the CAMmembranes yielded data on the effect
of MBG and Cu-MBG on a number of parameters, specifically
the total area occupied by vessels, the total length of the imaged
vessels, the average length between branching points, and the
number of branching points. Vessels over 20µm in diameter
are described as large vessels, those under 20µm in diameter
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FIGURE 6 | Tissue engineered infection skin model testing Cu-MBG activity against the formation and disruption of biofilms of two different bacterial species. (A)
Investigation of the Cu-MBG ability to prevent a biofilm formation on the skin models when tested with S. aureus and P. aeruginosa. (B) Investigation of the Cu-MBG
ability to disrupt a pre-existing biofilm growing on a tissue engineered skin model when tested against S. aureus and P. aeruginosa. n = 3, plotting mean ± standard
deviation, ANOVA statistics used. *p< 0.05.
FIGURE 7 | Optical images of aortic ring cell outgrowth in (A) control, (B) 30 ng/ml VEGF (C) MBG, and (D) Cu-MBG treated aortic rings. Arrows indicate examples of
outgrowth.
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FIGURE 8 | Response of aortic rings to treatment with VEGF, MBG and
Cu-MBG. Data is an average of three (MBG) and six (Cu-MBG) experiments
±/– SEM.
are described as small vessels. Controls were the CAM with
no treatment compared to CAM treated with 1mg MBG or
Cu-MBG. Example images are shown in Figure 9.
With respect to large vessels there was, a significant increase
in the total vessel length and the number of junctions in both
MBG and Cu-MBG treated CAM membranes (Figures 10C,D).
There was no significant effect of any treatment on the total area
covered by the large vessels or in the average length of the vessels
(Figures 10A,B). For small vessels, a different picture emerged.
There was a small increase in total vessel area with Cu-MBG
which was accompanied by a significant decrease in the total
vessel length (Figures 11A,B). There was a significant increase
in the average small vessel length for both MBG and Cu-MBG
(Figure 11C), and a significant fall in the number of junctions
for Cu-MBG but not MBG (Figure 11D).
DISCUSSION
Our aim was to develop multifunctional nanoparticles
to treat chronic wounds. To do this, in this study we
tested the ability of copper containing mesoporous glass
nanoparticles against bacterial infection and for their ability to
promote angiogenesis.
MBG nanoparticles containing 2% mol of copper were
successfully obtained through a base-catalyzed sol-gel route. The
incorporation of copper did not negatively affect the mesoporous
structure and the textural features of the particles, characterized
by specific surface area and a pore volume remarkably higher
than those of not-templated sol-gel glasses (Bari et al., 2017).
The copper releasing capability for up to 14 days was confirmed
quantitatively by ICP analysis, which evidenced an almost total
release after 72 h of soaking.
The effective antibacterial concentration of copper in
the Cu-MBG nanoparticles used was not cytotoxic to skin
cells in monolayer or to 3D human tissue engineered skin
constructs. With respect to the antimicrobial studies, our
data showed that the commercially available silver releasing
Acticoat Flex 3 was as effective or sometimes more potent than
Cu-MBG in both prevention and disruption of biofilms in
the infected skin model. However, it was also more cytotoxic
than the Cu-MBG nanoparticles. In clinical use, this degree of
cytotoxicity is known to cause problems as there is only a small
concentration difference between the concentration of silver
required to act as an antimicrobial and the concentration which
inhibits wound healing. Given the concentration of Cu2+ ions
released by the Cu-MBG, there is potential in future to use
a slightly increased concentration of these nanoparticles
to increase the antimicrobial activity without inducing
deleterious cytotoxicity.
Turning next to the desirability of inducing new vasculature
we were able to obtain some encouraging results on the effects
of Cu-MBG nanoparticles in stimulating angiogenesis. Many
chronic wounds suffer from poor vasculature and there have been
decades of research trying to develop biomaterials to promote
angiogenesis. VEGF is the best known and most potent of
the cascade of proangiogenic growth factors. However, topical
application of VEGF has proved disappointing clinically, and this
protein is labile and expensive. Thus, it is not being pursued
clinically, but it is routinely used as a positive control in
experimental studies of angiogenesis.
Copper ions have previously been shown to have a
proangiogenic effect (Zhao et al., 2015) and in the present
work we extended this proangiogenic study in a simple in
vitro assay of angiogenesis, the chick aortic ring assay—where
outgrowth of endothelial cells from rings of embryonic aorta
gives a measure of the degree to which the candidate material
promotes angiogenesis. We found that there was an overall
trend for a proangiogenic effect for both the MBG and Cu-
MBG nanoparticles. Both MBG systems showed outgrowth
between 50 and 75% of that seen with VEGF at 30 ng/mL.
At a dose of 1 mg/mL the fall off in outgrowth was more
marked where Cu was present, which could be due to
toxicity of Cu to cells. In fact, our cytotoxicity data in this
study demonstrated that at 1 mg/mL, Cu-MBG were toxic
to primary human fibroblasts in monolayers. The increase
in endothelial cell outgrowth even with MBG may be due
to the release of silicon ions. Silicate ions have been widely
reported to induce angiogenesis (Dashnyam et al., 2017a,b).
While both Si and Cu are reported to increase angiogenesis,
their content in the sample differs by more than one order
of magnitude. The high concentration of Si released from the
MBG could mask any proangiogenic effects due to an increase
in Cu concentration; hence we see an increased proangiogenic
effect from the Cu only when the Cu-MBG are at a low
concentration. Nonetheless, the Cu-MBG nanoparticles also
exhibit antibacterial properties.
Data from the CAM assay shows an increase in both the total
length and number of junctions of large vessels in response to
the presence of MBG, which were further increased in the case
of Cu-MBG. This proangiogenic effect may be a combination
of the effect of Si and Cu ions as discussed. Future studies may
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FIGURE 9 | Example of vasculature visible on CAM, images are processed to black and white for data processing, treated with (A) control MBG, (B) Cu-MBG.
FIGURE 10 | Effect of MBG and Cu-MBG nanoparticles on large vessels (over 20µm in diameter). (A) Total area of vessels per image, (B) Total length of vessel per
image, (C) Average length of vessels between junctions, and (D) Number of junctions per image. Data is an average of three experiments, each using six eggs per
treatment group, ± SEM. Statistical significance determined by T-test, *p < 0.05.
include a more detailed analysis of the pro-angiogenic properties
of the ions, for example by detection of angiogenic markers
expressed in vessels exposed to the ions by flow cytometry.
The results in small vessels show effects on the vessel area
and length, however it is difficult to interpret these data. Cu
released from Cu-MBG lead to an increase the visible area of
blood vessels and the average vessel length between junctions.
However, there was also a fall in both the total vessel length and
the number of junctions –while this may seem counterintuitive,
perhaps indicating that the population has an increased average
vessel diameter.
Cu-MBG displayed effective antibacterial properties against
clinical isolates of both Gram positive and Gram negative
bacteria, lending multifunctional aspects to these nanoparticles.
MBG without the addition of copper showed no measurable
antibacterial activity against either species used here, suggesting
that the antibacterial effects arise from the copper alone. In a
previous work (Bari et al., 2017) we reported the antibacterial
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FIGURE 11 | Effect of MBG and Cu-MBG nanoparticles on small vessels (under 20µm in diameter). (A) Total area of vessels per image, (B) Total length of vessel per
image, (C) Average length of vessels between junctions, and (D) Number of junctions per image. Data is an average of three experiments, each using six eggs per
treatment group, ± SEM. Statistical significance determined by T-test, *p < 0.05.
activity of the Cu-MBG against S. epidermidis and E. coli as
well as S. aureus, and the current results are consistent with
the antimicrobial action against both Gram positive and Gram
negative species tested previously published. Our microbiology
data suggests that the Cu-containing MBG nanoparticles are
more effective against P. aeruginosa than S. aureus. In this study
we expanded the antimicrobial work further by using infected 3D
models of tissue engineered human skin. In contrast to results
performed in tissue culture plastic, we found that, when using the
3Dmodel, P. aeruginosa were more resistant to treatment than S.
aureus. We postulate that this could be as a result of the ability
of P. aeruginosa to penetrate more deeply into the deep dermal
layers of tissue engineered skin, as previously observed by our
group (Shepherd et al., 2009; Zheng et al., 2019) thus escaping
the surface treatment. This supports the absolute necessity for the
use of more physiologically relevant 3D models in antimicrobial
research, rather than relying on 2D cell cultures or bacterial
biofilm in isolation of a relevant biological situation.
Other groups have developed multifunctional copper-
containing particles; for example Huang et al. (2017) have
modified the surface of titanium implants with a chitosan-gelatin
nanocomposite containing Cu ions. These composites also
have antibacterial and proangiogenic properties, however there
are limitations with respect to the usage since they are linked
to titanium. The nanoparticles described in this work are not
bound to a surface and could have a wide variety of potential
applications. For instance, we have recently shown that the
MBG nanoparticles can be incorporated into a thermosensitive
injectable polyurethane gel allowing targeted delivery of
therapeutic ions (Pontremoli et al., 2018).
CONCLUSION
In this contribution, multifunctional copper-containing
mesoporous glass nanoparticles were obtained through a
base-catalyzed sol-gel method. The spherical nanoparticles,
characterized by a large surface area and tunable pore size,
were able to release copper in a predictable way over 14 days.
They showed a remarkable antibacterial activity against both
planktonic and biofilm bacteria with a broad spectrum of
antimicrobial action, whilst showing no cytotoxicity in either 2D
cell monolayers or a 3D human skin model unlike a comparative
commercial dressing. A clear proangiogenic effect of both MBGs
and Cu-containing MBGs was confirmed by an increase in
endothelial cell outgrowth seen at concentrations between 30
and 300 µg/mL.
Overall, this study demonstrated the feasibility of producing
biocompatible multifunctional therapeutic Cu-containing MBGs
which are able to exert both antibacterial and proangiogenic
effects and, their appealing potential in development of
multifunctional devices.
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